Medicine – Scientific American

Adella Miesner

Biotechs and pharma want to protect patients without triggering immune system havoc 3 hours ago — Esther Landhuis Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news May 22, 2020 — Tanya Lewis Mosquitoes that like to bite at night are […]

Biotechs and pharma want to protect patients without triggering immune system havoc

3 hours ago — Esther Landhuis

Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news

May 22, 2020 — Tanya Lewis

Mosquitoes that like to bite at night are being thwarted by bed nets, leading to the rise of populations that prefer to bite when the nets are not up yet.

May 21, 2020 — Jason G. Goldman

Scientists urge caution over hints of success emerging from small human and animal studies

May 21, 2020 — Ewen Callaway and Nature magazine

Some individuals choosing physician-assisted death donate their tissue to science.

May 14, 2020 — Colin Barras and Nature magazine

Different species are helping answer different questions about COVID-19 in humans in order to develop vaccines and treatments

May 14, 2020 — سايمون جيه. ماكين

Blood tests that find malignancies before they spread could transform our approach to treatment…

The pandemic is no excuse to abandon chronic disease management and prevention

Despite conflicting data, the highly anticipated results will make the treatment a standard of care in the United States

April 30, 2020 — Heidi Ledford and Nature magazine

Amyloid, the leading target for dementia therapy, faces skepticism after drug failures

April 29, 2020 — Tanya Lewis

With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies

April 28, 2020 — Heidi Ledford and Nature magazine

Compassionate use of experimental medicine needs to coexist with scientific rigor to help patients, researchers write in the journal Science

April 24, 2020 — Anna Kuchment

Support grows for a controversial ‘human challenge’ vaccine study—but no trial is yet planned

April 22, 2020 — Ewen Callaway and Nature magazine

Research into the brain’s protein-disposal systems, electrical activity and three other areas looks promising

April 22, 2020 — Kenneth S. Kosik

Many hospitalized victims are developing potentially lethal secondary coinfections such as bacterial pneumonia and sepsis

Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials

April 16, 2020 — Tanya Lewis

In mice, a test for lung cancer involves nanoprobes that recognize tumors and send reporter molecules into the urine for simple analysis.

April 15, 2020 — W. Wayt Gibbs

A new era for Alzheimer’s and journalism in the time of coronavirus 

April 14, 2020 — Curtis Brainard

Originally published in June 1954

April 13, 2020

Slated for human trials, EIDD-2801 could become the first pill for COVID-19

April 7, 2020 — Michael Waldholz

Source Article

Next Post

Going to the Dentist During Covid-19: 10 Hygienist Tips

Dentists and Covid-19 Since the Covid-19 pandemic started, the Centers for Disease Control and Prevention (CDC) and the American Dental Association have asked dentists to forego routine and elective procedures in favor of emergency situations. This helped minimize the risk of infection to patients and staff and reduced the demand […]

You May Like